These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25523468)

  • 1. Quebec proposes to ban women over 42 from having IVF.
    Dyer O
    BMJ; 2014 Dec; 349():g7724. PubMed ID: 25523468
    [No Abstract]   [Full Text] [Related]  

  • 2. Outrage at planned changes to Quebec IVF.
    Morin V
    CMAJ; 2015 Feb; 187(2):E61. PubMed ID: 25534602
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal coverage of IVF pays off.
    Vélez MP; Connolly MP; Kadoch IJ; Phillips S; Bissonnette F
    Hum Reprod; 2014 Jun; 29(6):1313-9. PubMed ID: 24706002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating multiple pregnancies: an appropriate target for government intervention?
    Gleicher N
    Reprod Biomed Online; 2011 Oct; 23(4):403-6. PubMed ID: 21852194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will Quebec influence Ontario's IVF plans?
    Motluk A
    CMAJ; 2015 Jul; 187(10):E294. PubMed ID: 26009589
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurance coverage and in vitro fertilization outcomes: a U.S. perspective.
    Martin JR; Bromer JG; Sakkas D; Patrizio P
    Fertil Steril; 2011 Mar; 95(3):964-9. PubMed ID: 20688327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid policy change to single-embryo transfer while maintaining pregnancy rates per initiated cycle.
    Vélez MP; Kadoch IJ; Phillips SJ; Bissonnette F
    Reprod Biomed Online; 2013 May; 26(5):506-11. PubMed ID: 23507134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilisation policy in Israel and women's perspectives: the more the better?
    Birenbaum-Carmeli D; Dirnfeld M
    Reprod Health Matters; 2008 May; 16(31):182-91. PubMed ID: 18513619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model.
    Moolenaar LM; Broekmans FJ; van Disseldorp J; Fauser BC; Eijkemans MJ; Hompes PG; van der Veen F; Mol BW
    Fertil Steril; 2011 Oct; 96(4):889-94. PubMed ID: 21868001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Socioeconomic approach to the practice of in vitro fertilization in the Brittany region in 1993].
    Poulain P; Le Lannou D; Le Martelot MT; Vialard J; Chevalier R; Corvez A; Keraudren B; Taillanter L; Giraud JR
    Contracept Fertil Sex; 1995 Apr; 23(4):261-6. PubMed ID: 7757134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of in vitro fertilization.
    Collins J
    Semin Reprod Med; 2001 Sep; 19(3):279-89. PubMed ID: 11679909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection.
    Buckett WM; Chian RC; Dean NL; Sylvestre C; Holzer HE; Tan SL
    Fertil Steril; 2008 Sep; 90(3):546-50. PubMed ID: 17904128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resource allocation of in vitro fertilization: a nationwide register-based cohort study.
    Klemetti R; Gissler M; Sevón T; Hemminki E
    BMC Health Serv Res; 2007 Dec; 7():210. PubMed ID: 18154645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamete intrafallopian transfer. A cost-effective alternative to donor oocyte in vitro fertilization in women aged 40-42 years.
    Silva PD; Olson KL; Meisch JK; Silva DE
    J Reprod Med; 1998 Dec; 43(12):1019-22. PubMed ID: 9883404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment.
    Bouwmans CA; Lintsen BM; Eijkemans MJ; Habbema JD; Braat DD; Hakkaart L
    Fertil Steril; 2008 Feb; 89(2):331-41. PubMed ID: 17662286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic tubal reanastomosis versus in vitro fertilization: cost-based decision analysis.
    Hirshfeld-Cytron J; Winter J
    Am J Obstet Gynecol; 2013 Jul; 209(1):56.e1-6. PubMed ID: 23583214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Privately managed IVF (in vitro fertilization) is important and necessary].
    Nygren KG; Marsk L; Nylund L
    Lakartidningen; 1995 Nov; 92(44):4110-2. PubMed ID: 8538281
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified natural cycle in vitro fertilization an alternative in vitro fertilization treatment with lower costs per achieved pregnancy but longer treatment time.
    von Wolff M; Rohner S; Santi A; Stute P; Popovici R; Weiss B
    J Reprod Med; 2014; 59(11-12):553-9. PubMed ID: 25552127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic impact of the assisted reproductive technologies.
    Katz P; Nachtigall R; Showstack J
    Nat Cell Biol; 2002 Oct; 4 Suppl():s29-32. PubMed ID: 12479612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who is my mother?: why states should ban posthumous reproduction by women.
    Antall KL
    Health Matrix Clevel; 1999; 9(1):203-34. PubMed ID: 10538191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.